- Report
- October 2024
- 199 Pages
Global
From €3351EUR$3,545USD£2,847GBP
€3723EUR$3,939USD£3,164GBP
- Report
- February 2025
- 200 Pages
Global
From €4244EUR$4,490USD£3,606GBP
- Report
- February 2025
- 183 Pages
Global
From €4253EUR$4,500USD£3,614GBP
- Report
- January 2025
- 183 Pages
Global
From €4253EUR$4,500USD£3,614GBP
- Report
- March 2024
- 238 Pages
Global
From €7514EUR$7,950USD£6,385GBP
- Report
- July 2023
- 284 Pages
Global
From €3403EUR$3,600USD£2,891GBP
- Report
- July 2023
- 145 Pages
Asia Pacific
From €1418EUR$1,500USD£1,205GBP
- Report
- October 2024
- 80 Pages
Global
From €3500EUR$3,967USD£3,078GBP
- Report
- November 2024
- 78 Pages
Global
From €3500EUR$3,967USD£3,078GBP
- Report
- June 2023
- 313 Pages
Global
From €3374EUR$3,570USD£2,867GBP
- Book
- October 2019
- 720 Pages
Ampicillin is an antibiotic drug used to treat a wide range of bacterial infections. It belongs to the penicillin group of antibiotics and is commonly used to treat infections of the ear, nose, throat, urinary tract, and skin. It is also used to treat certain types of meningitis, gonorrhea, and other infections caused by bacteria. Ampicillin is available in both oral and injectable forms.
Ampicillin is a widely used antibiotic in the treatment of bacterial infections. It is effective against a wide range of bacteria, including Gram-positive and Gram-negative bacteria. It is also used in combination with other antibiotics to treat more serious infections.
The market for Ampicillin is highly competitive, with many companies offering different formulations of the drug. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. Show Less Read more